Profound Medical Corp. (TSX: PRN)
Canada
· Delayed Price · Currency is CAD
10.61
+0.06 (0.57%)
Nov 22, 2024, 3:59 PM EST
Profound Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -31.39 | -28.57 | -28.67 | -30.7 | -21.62 | -15.22 | Upgrade
|
Depreciation & Amortization | 0.84 | 0.97 | 1 | 1.01 | 0.81 | 0.8 | Upgrade
|
Other Amortization | 0.32 | 0.18 | 0.6 | 0.87 | 0.73 | 0.72 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 2.52 | - | - | - | Upgrade
|
Stock-Based Compensation | 3.05 | 3.42 | 4.24 | 7.21 | 3.02 | 1.27 | Upgrade
|
Other Operating Activities | 0.79 | 1.34 | 0.13 | 0.13 | 1.13 | 1.13 | Upgrade
|
Change in Accounts Receivable | -0.49 | -0.96 | -1.42 | 2 | -4.03 | -1.03 | Upgrade
|
Change in Inventory | 0.59 | 0.35 | -1.86 | -2.49 | -2.14 | -0.85 | Upgrade
|
Change in Accounts Payable | 1.35 | 1.36 | -0.57 | -0.36 | 0.1 | -0.08 | Upgrade
|
Change in Income Taxes | -0.33 | -0.3 | 0.31 | -0.01 | 0 | -0.21 | Upgrade
|
Change in Other Net Operating Assets | 0.39 | -0.14 | -2.09 | -0.01 | 1.25 | -1.74 | Upgrade
|
Operating Cash Flow | -24.83 | -22.3 | -25.8 | -22.36 | -20.57 | -15.05 | Upgrade
|
Capital Expenditures | - | - | - | -0.03 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | - | - | -0.56 | -0.35 | -0.19 | Upgrade
|
Investing Cash Flow | - | - | - | -0.59 | -0.35 | -0.19 | Upgrade
|
Long-Term Debt Issued | - | - | 7.27 | - | - | - | Upgrade
|
Total Debt Issued | - | - | 7.27 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -1.2 | -0.36 | -0.39 | -9.61 | -1.25 | Upgrade
|
Total Debt Repaid | -2.53 | -1.2 | -0.36 | -0.39 | -9.61 | -1.25 | Upgrade
|
Net Debt Issued (Repaid) | -2.53 | -1.2 | 6.92 | -0.39 | -9.61 | -1.25 | Upgrade
|
Issuance of Common Stock | 22.94 | 2.67 | 0.26 | 6.43 | 103.68 | 8.71 | Upgrade
|
Other Financing Activities | -1.86 | - | -0.15 | -0.1 | -6.64 | -0.87 | Upgrade
|
Financing Cash Flow | 18.55 | 1.46 | 7.03 | 5.95 | 87.43 | 6.6 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.23 | 0.53 | -1.87 | 0.24 | 2.6 | 0.95 | Upgrade
|
Net Cash Flow | -6.5 | -20.3 | -20.64 | -16.76 | 69.11 | -7.7 | Upgrade
|
Free Cash Flow | -24.83 | -22.3 | -25.8 | -22.39 | -20.57 | -15.05 | Upgrade
|
Free Cash Flow Margin | -276.36% | -309.72% | -386.17% | -325.80% | -281.68% | -360.57% | Upgrade
|
Free Cash Flow Per Share | -1.05 | -1.05 | -1.24 | -1.09 | -1.19 | -1.36 | Upgrade
|
Levered Free Cash Flow | -14.79 | -13.4 | -18.78 | -7.22 | -13.31 | -10.78 | Upgrade
|
Unlevered Free Cash Flow | -14.36 | -12.92 | -18.68 | -7.18 | -12.97 | -10.13 | Upgrade
|
Change in Net Working Capital | -2.11 | -0.4 | 6.02 | -3.26 | 5.39 | 3.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.